Novo Nordisk is phasing out human insulin pens to focus on its newer diabetes and obesity medicines, sparking protests and concerns over access in low-income countries. Modern insulin, preferred in ...

Novo Nordisk is gradually ending production of human insulin pens, a spokesperson confirmed to Reuters. Instead, the company is channeling investments into manufacturing its popular obesity and ...

“To address our current capacity constraints and reach more people with diabetes with our products in the future, our human insulin, which is currently delivered in pens and vials, will—over ...

“Until we do find a cure and continue to make advancements like this where you can take insulin without a needle, that's such a huge impact for people living with this daily challenge,” said Jarvi ...

Sequel Medtech is working to sell a new, more precise type of insulin pump that can measure the amount of insulin delivered to users. CEO Alan Lotvin, former president of pharmacy benefit manager CVS ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ... needles. There is evidence people in LMICs want to use pens.

And then there’s my insulin pen, discreet and almost painless to use. Insulin is a human right, fundamental to life. Yet, paradoxically, it is more accessible to some than to others. For those ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...